{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:54:30Z","timestamp":1793318070110,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62371221"],"award-info":[{"award-number":["62371221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["12326616"],"award-info":[{"award-number":["12326616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National High-end Foreign Experts Recruitment Plan","award":["G2023030025L"],"award-info":[{"award-number":["G2023030025L"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00259-025-07594-4","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:16:30Z","timestamp":1761815790000},"page":"2604-2621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AI-Quantified \u00b9\u00b9C-MET PET\/CT bone marrow metabolic activity for prognostic assessment in newly diagnosed multiple myeloma"],"prefix":"10.1007","volume":"53","author":[{"given":"Zanting","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-4892","authenticated-orcid":false,"given":"Lijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"77","key":"7594_CR1","first-page":"1","volume":"8","author":"S Chhabra","year":"2015","unstructured":"Chhabra S, Jain S, Wallace C, et al. High expression of Endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma. J Hematol Oncol. 2015;8(77):1\u20139.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"7594_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28(5):1122\u20138.","journal-title":"Leukemia"},{"issue":"9","key":"7594_CR3","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1182\/bloodadvances.2022007052","volume":"6","author":"C Charalampous","year":"2022","unstructured":"Charalampous C, Goel U, Broski SM, et al. Utility of PET\/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma. Blood Adv. 2022;6(9):2763\u201372.","journal-title":"Blood Adv"},{"issue":"12","key":"7594_CR4","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"14","key":"7594_CR5","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1200\/JCO.2010.32.5449","volume":"29","author":"E Terpos","year":"2011","unstructured":"Terpos E, Moulopoulos LA, Dimopoulos MA. Advances in imaging and the management of myeloma bone disease. J Clin Oncol. 2011;29(14):1907\u201315.","journal-title":"J Clin Oncol"},{"issue":"12","key":"7594_CR6","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ejrad.2014.09.012","volume":"83","author":"C Mesguich","year":"2014","unstructured":"Mesguich C, Fardanesh R, Tanenbaum L, et al. State of the art imaging of multiple myeloma: comparative review of FDG PET\/CT imaging in various clinical settings. Eur J Radiol. 2014;83(12):2203\u201323.","journal-title":"Eur J Radiol"},{"issue":"4","key":"7594_CR7","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, et al. Role of \u00b9\u2078F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the international myeloma working group. Lancet Oncol. 2017;18(4):e206\u201317.","journal-title":"Lancet Oncol"},{"issue":"2","key":"7594_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1148\/radiol.2422051980","volume":"242","author":"A Dankerl","year":"2007","unstructured":"Dankerl A, Liebisch P, Glatting G, et al. Multiple myeloma: molecular imaging with \u00b9\u00b9c-methionine PET\/CT\u2014initial experience. Radiology. 2007;242(2):498\u2013508.","journal-title":"Radiology"},{"issue":"4","key":"7594_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/cancers12041042","volume":"12","author":"MI Morales-Lozano","year":"2020","unstructured":"Morales-Lozano MI, Viering O, Samnick S, et al. \u00b9\u2078F-FDG and \u00b9\u00b9C-Methionine PET\/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers. Cancers (Basel). 2020;12(4):1042.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"7594_CR10","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.18632\/oncotarget.3053","volume":"6","author":"K L\u00fcckerath","year":"2015","unstructured":"L\u00fcckerath K, Lapa C, Albert C, et al. \u00b9\u00b9C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma. Oncotarget. 2015;6(10):8418\u201329.","journal-title":"Oncotarget"},{"issue":"11","key":"7594_CR11","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.7150\/thno.20491","volume":"7","author":"C Lapa","year":"2017","unstructured":"Lapa C, Garcia-Velloso MJ, L\u00fcckerath K, et al. \u00b9\u00b9C-methionine-PET in multiple myeloma: a combined study from two different institutions. Theranostics. 2017;7(11):2956\u201364.","journal-title":"Theranostics"},{"issue":"4","key":"7594_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2214\/AJR.22.28560","volume":"220","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yee A, Bernstein Z, et al. \u00b9\u00b9C-labeled methionine PET\/CT in patients with FDG-occult multiple myeloma: a prospective pilot study. AJR Am J Roentgenol. 2023;220(4):578\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"7594_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s00259-012-2333-3","volume":"40","author":"Y Nakamoto","year":"2013","unstructured":"Nakamoto Y, Kurihara K, Nishizawa M, et al. Clinical value of \u00b9\u00b9C-methionine PET\/CT in patients with plasma cell malignancy: comparison with \u00b9\u2078F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2013;40(5):708\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"17","key":"7594_CR14","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.3390\/ijms23179895","volume":"23","author":"MI Morales-Lozano","year":"2022","unstructured":"Morales-Lozano MI, Rodriguez-Otero P, Sancho L, et al. \u00b9\u00b9C-methionine PET\/CT in assessment of multiple myeloma patients: comparison to \u00b9\u2078F-FDG PET\/CT and prognostic value. Int J Mol Sci. 2022;23(17):9895.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7594_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00277-019-03852-2","volume":"99","author":"R Fonti","year":"2020","unstructured":"Fonti R, Pellegrino S, Catalano L, et al. Visual and volumetric parameters by \u00b9\u2078F-FDG-PET\/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma. Ann Hematol. 2020;99(1):127\u201335.","journal-title":"Ann Hematol"},{"issue":"12","key":"7594_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2967\/jnumed.112.106500","volume":"53","author":"R Fonti","year":"2012","unstructured":"Fonti R, Larobina M, Del Vecchio S, et al. Metabolic tumor volume assessed by \u00b9\u2078F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma. J Nucl Med. 2012;53(12):1829\u201335.","journal-title":"J Nucl Med"},{"issue":"8","key":"7594_CR17","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1158\/1078-0432.CCR-16-0235","volume":"23","author":"JE McDonald","year":"2017","unstructured":"McDonald JE, Kessler MM, Gardner MW, et al. Assessment of total lesion Glycolysis by \u00b9\u2078F FDG PET\/CT significantly improves prognostic value of GEP and ISS in myeloma. Clin Cancer Res. 2017;23(8):1981\u20137.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7594_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-020-00346-3","volume":"7","author":"AJ Weisman","year":"2020","unstructured":"Weisman AJ, Kim J, Lee I, et al. Automated quantification of baseline imaging PET metrics on FDG PET\/CT images of pediatric hodgkin lymphoma patients. EJNMMI Phys. 2020;7(1):1\u201312.","journal-title":"EJNMMI Phys"},{"issue":"3","key":"7594_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00259-015-3200-9","volume":"43","author":"C Nanni","year":"2016","unstructured":"Nanni C, Zamagni E, Versari A, et al. Image interpretation criteria for FDG PET\/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPetus (Italian myeloma criteria for PET use). Eur J Nucl Med Mol Imaging. 2016;43(3):414\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7594_CR20","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00259-024-06668-z","volume":"51","author":"C Sachpekidis","year":"2024","unstructured":"Sachpekidis C, Enqvist O, Ul\u00e9n J, et al. Artificial intelligence\u2013based, volumetric assessment of the bone marrow metabolic activity in [\u00b9\u2078F] FDG PET\/CT predicts survival in multiple myeloma. Eur J Nucl Med Mol Imaging. 2024;51(8):2293\u2013307.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"7594_CR21","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00259-023-06339-5","volume":"50","author":"C Sachpekidis","year":"2023","unstructured":"Sachpekidis C, Enqvist O, Ul\u00e9n J, et al. Application of an artificial intelligence-based tool in [\u00b9\u2078F] FDG PET\/CT for the assessment of bone marrow involvement in multiple myeloma. Eur J Nucl Med Mol Imaging. 2023;50(12):3697\u2013708.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7594_CR22","volume":"5","author":"J Wasserthal","year":"2023","unstructured":"Wasserthal J, Breit H, Meyer MT, et al. Totalsegmentator: robust segmentation of 104 anatomic structures in CT images. Radiology: Artificial Intelligence. 2023;5(5):e230024.","journal-title":"Radiology: Artificial Intelligence"},{"issue":"2","key":"7594_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41592-020-01008-z","volume":"18","author":"F Isensee","year":"2021","unstructured":"Isensee F, Jaeger PF, Kohl SA, et al. Nnu-net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18(2):203\u201311.","journal-title":"Nat Methods"},{"issue":"1","key":"7594_CR24","doi-asserted-by":"publisher","first-page":"16429","DOI":"10.1038\/s41598-019-52740-2","volume":"9","author":"ME Takahashi","year":"2019","unstructured":"Takahashi ME, Mosci C, Souza EM, et al. Proposal for a quantitative \u00b9\u2078F-FDG PET\/CT metabolic parameter to assess the intensity of bone involvement in multiple myeloma. Sci Rep. 2019;9(1):16429.","journal-title":"Sci Rep"},{"issue":"1","key":"7594_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O Doherty MJ, Weber WA, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"7594_CR26","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/diagnostics13122009","volume":"13","author":"L Filippi","year":"2023","unstructured":"Filippi L, Frantellizzi V, Bartoletti P, et al. Head-to-head comparison between FDG and \u00b9\u00b9C-Methionine in multiple myeloma: a systematic review. Diagnostics (Basel). 2023;13(12):2009.","journal-title":"Diagnostics (Basel)"},{"issue":"15","key":"7594_CR27","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, Miguel JS, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412\u201320.","journal-title":"J Clin Oncol"},{"issue":"26","key":"7594_CR28","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015;33(26):2863\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"7594_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12149-014-0931-9","volume":"29","author":"M Okasaki","year":"2015","unstructured":"Okasaki M, Kubota K, Minamimoto R, et al. Comparison of \u00b9\u00b9C-4\u2032-thiothymidine, \u00b9\u00b9C-methionine, and \u00b9\u2078F-FDG PET\/CT for the detection of active lesions of multiple myeloma. Ann Nucl Med. 2015;29(3):224\u201332.","journal-title":"Ann Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07594-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07594-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07594-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:38:50Z","timestamp":1771479530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07594-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["7594"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07594-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Approval No. ZF2021-196-01). Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The written informed consent was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}